Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells ; volume:10 ; number:1 ; day:24 ; month:8 ; year:2024 ; pages:1-12 ; date:12.2024
Cell death discovery ; 10, Heft 1 (24.8.2024), 1-12, 12.2024

Urheber
Alraouji, Noura N.
Colak, Dilek
Al-mohanna, Falah H.
Alaiya, Ayodele A.
Aboussekhra, Abdelilah
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41420-024-02151-8
URN
urn:nbn:de:101:1-2411121026149.273887215644
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:28 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Alraouji, Noura N.
  • Colak, Dilek
  • Al-mohanna, Falah H.
  • Alaiya, Ayodele A.
  • Aboussekhra, Abdelilah
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19

OPG Nachsortierung (Bestand)

Bestand

OPG Nachsortierung (Bestand)

Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen

Hochschulschrift

Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis

Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse

Hochschulschrift

Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse

Offizierpensionsgesetz (O.P.G.) nebst Ausführungsbestimmungen

Archivale

Offizierpensionsgesetz (O.P.G.) nebst Ausführungsbestimmungen

AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA

AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA

Verbundene Objekte